News

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the ...
Apalutamide decreased risk of death in mCSPC by 23% and 26% compared with enzalutamide and abiraterone acetate, respectively.
The MindCap mobile app is likely feasible as an assessment for cognitive function of cancer survivors, although further data ...
The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable ...
Panelists discuss how cardiovascular toxicity remains a significant concern with certain tyrosine kinase inhibitors (TKIs) used in chronic myeloid leukemia (CML) treatment, particularly with the older ...
Panelists discuss how eliminating the strict mealtime restrictions with the new nilotinib formulation addresses a significant unmet need in chronic myeloid leukemia (CML) treatment by reducing ...
Data from the CEPHEUS trial support the use of D-VRd in patients with transplant-ineligible or -deferred multiple myeloma who can tolerate bortezomib. Adding daratumumab (Darzalex) to bortezomib ...
Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing ...
Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian ...
Providing education about patients’ diseases was difficult, according to 32% of registered nurses and 29% of infusion nurses.
Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving ...
Social determinants of health like transportation and financial increased the occurrence of psychoneurological symptoms in ...